Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (215)	7/15/1999 12:07:00 PM
From: T-Lo Greens	Read Replies (1) \| Respond to of 2557

Rudy while I can't predict the future, past indications of stocks with similar run-ups due to some technological discovery or breakthrough will usually retrace to their original pre-announcement price. I hope you are protecting your profits. Cheers! Tony

To: Rudy Saucillo who wrote (215)	8/22/1999 10:25:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2557

Rudy: You can rest assured that VPHM won't go back to 9. But I'll be thrilled when you and the rest of the traders are gone from this thread! At $16, a clean 2X from the beginning of July. Congrats! I think it's safe to talk science again. Note that Yahoo says that the shares described in this post...... Message 10523386 were sold on 7/2, 10 days before the date given for filing and well before results of "cold" trial were released, at an average price of $7.86. That's some insider trading to fear. Not. The pipeline........ RSV, 1 nM potent, bioavail if inhaled, tox > 20 mg/kg. HCV target for clinic was late '99, oral bioavail, tox > 100 mg/kg. Message 10521639 Rick